The functional logic of cytosolic 5'-nucleotidases

Current Medicinal Chemistry

Volumn 20, Issue 34, 2013, Pages 4205-4216

  Ipata, P L ^a   Balestri, F ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

5' nucleotidases; CN IA; CN II; CN III; Nucleoside recycling; Nucleoside utilization

Indexed keywords

5' NUCLEOTIDASE; 6 PHOSPHOFRUCTOKINASE; ADENINE NUCLEOTIDE; ADENOSINE; ADENOSINE DEAMINASE; ADENOSINE DIPHOSPHATE; ADENOSINE MONOPHOSPHATE DEAMINASE; ADENOSINE PHOSPHATE; ADENOSINE TRIPHOSPHATE; ADENYLATE KINASE; ADENYLOSUCCINATE LYASE; ADENYLOSUCCINATE SYNTHASE; CYTIDINE DEAMINASE; ECTO 5' NUCLEOTIDASE; ENZYME; GLYCOGEN PHOSPHORYLASE; GUANOSINE PHOSPHATE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE; METFORMIN; MYOSIN ADENOSINE TRIPHOSPHATASE; NUCLEOSIDE DIPHOSPHATE KINASE; NUCLEOSIDE TRIPHOSPHATE; PHOSPHOMANNOMUTASE; PURINE NUCLEOSIDE PHOSPHORYLASE; PURINE NUCLEOTIDE; PYRIMIDINE DERIVATIVE; UNINDEXED DRUG; URIDINE KINASE; URIDINE PHOSPHORYLASE;

ARTICLE; BINDING SITE; CATALYSIS; CELL METABOLISM; CELL STRESS; CYTOSOL; DEPHOSPHORYLATION; ENERGY METABOLISM; ENZYME ACTIVITY; ESCHERICHIA COLI; FIBROBLAST; HUMAN; MONONUCLEAR CELL; NONHUMAN; OXIDATIVE PHOSPHORYLATION;

5'-NUCLEOTIDASE; ANIMALS; BRAIN; CYTOSOL; ENERGY METABOLISM; HUMANS; ISCHEMIA;

EID: 84887859867     PISSN: 09298673     EISSN: 1875533X     Source Type: Journal    
DOI: 10.2174/0929867311320340002     Document Type: Article

References (126)

1. Dobson, J.G. Jr.; Rubio, R.; Berne, R.M. Role of adenine nucleotides, adenosine, and inorganic phosphate in the regulation of skeletal muscle blood flow. Circ. Res., 1971, 29(4), 375-384.
2. Rubio, R.; Berne, R.M; Bockman, E.L.; Curnish, R.R. Relationship between adenosine concentration and oxygen supply in rat brain. Am. J. Physiol., 1975, 228(6), 1896-1902.
3. Latini, C.; Pedata, F. Adenosine in the central nervous system: Release mechanisms and extracellular concentrations. J. Neurochem., 2001, 79(3), 463-484.
4. Cunha, R. A. Adenosine as a neuromodulator and as a homeostatic regulator in the nervous system: different roles, different sources and different receptors. Neurochem. Int., 2001, 38(2), 107-125.
5. Burnstock, G.; Fredholm, B.; Verkhratsky, A. Adenosine and ATP receptors in the brain. Curr. Top. Med. Chem., 2011, 11(8), 973-1011.
6. Rathbone, M.; Pilutti, L.; Caciagli, F.; Jiang, S. Neurotrophic effects of extracellular guanosine. Nucleosides Nucleotides Nucleic Acids, 2008, 27(6) 666-672.
7. Lecca, D.; Ceruti, S. Uracil nucleotides: from metabolic intermediates to neuroprotection and neuroinflammation. Biochem. Pharmacol., 2008, 75(10), 1869-1881.
8. Cansev, M.; Marzloff, G.; Sakamoto, T.; Ulus, I.H.; Wurtman, R. J. Giving uridine and/or docosahexaenoic acid orally to rat dams during gestation and nursing increases synaptic elements in brain of weanling pups. Dev. Neurosci., 2009, 31(3), 181-192.
9. Dobolyi, A.; Juhász, G.; Kovács, Z.; Kardos, J. Uridine function in the central nervous system. Curr. Top. Med. Chem., 2011, 11(8), 1058-1067.
10. Cansev, M. Uridine and cytidine in the brain: their transport and utilization. Brain Res. Rev., 2006, 52(2), 389-397.
11. Balestri, F.; Giannecchini, M.; Sgarrella, F.; Carta, M.C.; Tozzi, M.G.; Camici, M. Purine and pyrimidine nucleosides preserve human astrocytoma cell adenylate energy charge under ischemic conditions. Neurochem. Int., 2007, 50(3), 517-523.
12. Giannecchini, M.; Matteucci, M.; Pesi, R.; Sgarrella, F.; Tozzi, M.G.; Camici, M. Uptake and utilization of nucleosides for energy repletion. Int. J. Biochem. Cell Biol., 2005, 37(4), 797-808.
13. Jurkowitz, M.S.; Litsky, M.L.; Browning, M.J.; Hohl, C.M. Adenosine, inosine, and guanosine protect glial cells during glucose deprivation and mitochondrial inhibition: correlation between protection and ATP preservation. J. Neurochem., 1998, 71(2), 535-548.
14. Tozzi, M.G.; Camici, M.; Mascia, L.; Sgarrella, F.; Ipata, P.L. Pentose phosphates in nucleoside interconversion and catabolism. FEBS J., 2006, 273(6), 1089-1101.
15. Reis, M.J. Nucleotidase and its relation to the deamination of nucleotides in the heart and the muscles. Bull. Soc. Chim. Biol., 1934, 16, 385-399.
16. Arch, J.R.; Newsholme, E.A. The control of the metabolism and the hormonal role of adenosine. Essays Biochem., 1978, 14, 82-123.
17. Langer, D.; Hammer, K.; Koszalka, P.; Schrader, J.; Robson, S.; Zimmermann, H. Distribution of ectonucleotidases in the rodent brain revisited. Cell Tissue Res., 2008, 334(2), 199-217.
18. Yegutkin, G. Nucleotide-and nucleoside-converting ectoenzymes: important modulators of purinergic signalling cascade. Biochim. Biophys. Acta, 2008, 1783(5), 673-694.
19. Truong,V.L.; Collinson, A.R.; Lowenstein, J. M. 5'-Nucleotidases in rat heart. Evidence for occurrence of two soluble enzymes with different substrate specificities. Biochem. J., 1988, 253(1), 117-121.
20. Skladanowski, A.C.; Newby, A.C. Partial purification and properties of AMP-specific soluble 5'-nucleotidase from pigeon heart. Biochem. J., 1990, 268(1), 117-122.
21. Tkacz-Stachowska, K.; Lechward, K.; Skladanowski, A. Isolation and characterization of pigeon breast muscle cytosolic 5'-nucleotidase-I (cN-I). Acta Biochimica Polonica, 2005, 52(4), 789-796.
22. Mallol, J.; Bozal, J. 5'-Nucleotidase from bovine brain cortex: effect of solubilization on enzyme kinetics and modulation, Neurochem. Int., 1988, 12(1), 61-67.
23. Barsotti, C.; Ipata, P.L. Metabolic regulation of ATP breakdown and of adenosine production in rat brain extracts., Int. J. Biochem. Cell Biol., 2004, 36(11), 2214-2225.
24. Zimmermann, H. 5'-Nucleotidase: molecular structure and functional aspects. Biochemical J., 1992, 285(Pt 2), 345-365.
25. Zimmermann, H. Biochemistry, localization and functional roles of ecto-nucleotidases in the nervous system. Prog. Neurobiol., 1996, 49(6), 589-618.
26. Itoh, R.; Mitsui, A.; Tsushima, K. 5'-nucleotidase of chicken liver. Biochim. Biophys. Acta, 1967, 146(1), 151-159.
27. Pesi, R.; Turriani, M.; Allegrini, S.; Scolozzi, C.; Camici, M.; Ipata, P.; Tozzi, M.G. The bifunctional cytosolic 5'-nucleotidase: regulation of the phosphotransferase and nucleotidase activities. Arch. Biochem. Biophys., 1994, 312(1), 75-80.
28. Pesi, R.; Baiocchi, C.; Allegrini, S.; Moretti, E.; Sgarrella, F.; Camici, M.; Tozzi, M.G. Identification, separation and characterization of two forms of cytosolic 5'-nucleotidase/nucleoside phosphotransferase in calf thymus. Biol. Chem., 1998, 379(6), 699-704.
29. Itoh, R. IMP-GMP 5'-nucleotidase. Comp. Biochem. Physiol., 1993, 105(1), 13-19.
30. Amici, A.; Magni, G. Humanhttp://www.ncbi.nlm.nih.gov/pubmed/ 11795870 erythrocytehttp://www.ncbi.nlm.nih.gov/pubmed/ 1179 5870 pyrimidine 5'-nucleotidase, PN-I. Arch. Biochem. Biophys., 2002, 397(2), 184-90.
31. Marinaki, A.M.; Escuredo, E.; Duley, J.A.; Simmonds, H.A.; Amici, A.; Naponelli, V.; Magni, G.; Seip, M.; Ben-Bassat, I.; Harley, E.H.; Thein, S.L.; Rees, D.C. Genetic basis of hemolytic anemia caused by pyrimidine 5'-nucleotidase deficiency. Blood, 2001, 97(11), 3327-3332.
32. Bianchi,V.; Spychala, J. Mammalian 5'-nucleotidases. J. Biol. Chem., 2003, 278(47), 46195-46198.
33. Nelson, D.L.; Cox, M.M. Principles of Biochemistry, 5th edition, Freiman and Company, 2008.
34. Allsop, J.; Watts, R.W. Purine de novo synthesis in liver and developing rat brain, and the effect of some inhibitors of purine nucleotide interconversion. Enzyme, 1983, 30(3), 172-180.
35. Allsop, J.; Watts, R.W. Purine synthesis and salvage in brain and liver. Adv. Exp. Med. Biol., 1984, 165(Pt B), 21-26.
36. Bourget, P.A.; Trembly, G.C. Pyrimidine biosynthesis in rat brain. J. Neurochemistry, 1972, 19(7), 1617-1624.
37. Ipata, P.L.; Camici, M.; Micheli, V.; Tozzi, M.G. Metabolic network of nucleosides in the brain. Curr. Top. Med. Chem., 2011, 11(8), 909-922.
38. Sala-Newby, G.B.; Freeman, N.V.E.; Skladanowski, A.C.; Newby, A.C. Distinct roles for recombinant cytosolic 5'-nucleotidase-I and II in AMP and IMP catabolism in COS-7 and H9c2 rat myoblast cell lines. J. Biol. Chem., 2000, 275(16), 11666-11671.
39. Bogan, K.L.; Brenner, C. 5'-Nucleotidases and their new roles in NAD+ and phosphate metabolism. New J. Chem., 2010, 34, 845-853.
40. Sala-Newby, G.B.; Skladanowski, A.C.; Newby, A.C. The mechanism of adenosine formation in cells. Cloning of cytosolic 5'-nucleotidase-I. J. Biol. Chem. 1999, 274(25), 17789-17793.
41. Chen, W.; Hoerter, J.; Guéron, M. A comparison of AMP degradation in perfused rat heart during 2-deoxy-D-glucose perfusion and anoxia. Part I: the release of adenosine and inosine. J. Mol. Cell Cardiol., 1996, 28(10), 2163-2174.
42. Fredholm, B.B.; Dunwiddie, T.V.; Bergman, B.; Lindstrom, K. Levels of adenosine and adenine nucleotides in slices of rat hippocampus. Brain Res., 1984, 295(1), 127-136.
43. Tomoyuki, K., Takeshi, Y., Yasuhiro, O. The levels of adenosine and its metabolites in the guinea pig and rat brain during complete ischemia-in vivo study. Brain Res., 1998, 787(2), 211-219.
44. Ljunggren, B.; Ratcheson, R.A.; Siesjo, B.K. Cerebral metabolic state following complete compression ischemia. Brain Res., 1974, 73(2), 291-307.
45. Phillis J.W.; O'Regan, M.H.; Estevez, A.Y.; Song, D.; Vander-Heide, S.J. Cerebral Energy Metabolism During Severe Ischemia of Varying Duration and Following Reperfusion. J. Neurochemistry, 1996, 67(4), 1525-1531.
46. Chen.W.; Gueron, M. AMP degradation in the perfused rat heart during 2-deoxy-D-glucose perfusion and anoxia. Part II: the determination of the degradation pathways using an adenosine deaminase inhibitor. J. Mol. Cell Cardiol., 1996, 28(10), 2175-2182.
47. Krebs, H. The Croonian Lecture, 1963: Gluconeogenesis. Proceedings of the Royal Society of London., 1964, 159(977), 545-564.
48. Hardie, D.G.; Ross, F.A.; Hawley, S.A. AMPK: a nutrient and energy sensor that maintains energy homeostasis. Nat. Rev. Mol. Cell Biol., 2012, 13(4), 251-262.
49. Ramaiah, A.; Hathaway, J.A.; Atkinson, D.E. Adenylate as a metabolic regulator effect on yeast phosphofructokinase kinetics. J. Biol. Chem., 1964, 239, 3619-3622.
50. Klinov, S.V.; Kurganov, B.I. Kinetic mechanism of activation of muscle glycogen phosphorylase b by adenosine 5'-monophosphate. Arch. Biochem. Biophys., 1994, 312(1), 14-21.
51. Kurganov, B. I.; Schors, E.I.; Klinov, S.V.; Chebotareva, N.A. Slow step in activation of muscle glycogen phosphorylase b by adenosine 5'-monophosphate. Biochem. Mol. Biol. Int., 1995, 36(1), 155-161.
52. Johnson L.N.; Barford, D. Glycogen phosphorylase. The structural basis of the allosteric response and comparison with other allosteric proteins. J. Biol. Chem., 1990, 265(5), 2409-2412.
53. Hofmann, E. The significance of phosphofructokinase to the regulation of carbohydrate metabolism. Rev. Physiol. Biochem. Pharmacol., 1976, 75, 1-68.
54. Hofmann, E.; Kopperschlager, G. Phosphofructokinase from yeast. Methods Enzymol., 1982, 90(Pt E), 49-60.
55. Uyeda, K. Phosphofructokinase. Adv. Enzymol. Relat. Areas Mol. Biol., 1979, 48, 193-244.
56. Brüser, A.; Kirchberger, J.; Schöneberg, T. Altered allosteric regulation of muscle 6-phosphofructokinase causes Tarui disease. Biochem. Biophys. Res. Commun., 2012, 427(1), 133-137.
57. Hardie, D. AMPK: a key regulator of energy balance in the single cell and the whole organism. Int. J. Obes., 2008, 32(Suppl.4), S7-S12.
58. Winder, W.W. Energy sensing by the AMP-activated protein kinase and its effects on muscle metabolism. J. Appl. Physiol, 2001, 91(2), 1017-1028.
59. Carling, D. The AMP-activated protein kinase cascade: a unifying system for energy control. Trends in Biochem. Sciences, 2004, 29(1), 18-24.
60. Ramamurthy, S.; Ronnett, G. AMP-activated protein kinase (AMPK) and energy-sensing in the brain. Exp. Neurobiol., 2012, 21(2), 52-60.
61. Ahn, Y.J.; Kim, H.; Lim, H.; Lee, M.; Kang, Y.; Moon, S.; Kim, H.S.; Kim, H.H.AMP-activated protein kinase: implications on ischemic diseases. BMB Rep., 2012, 45(9), 489-495.
62. Bak, M.I.; Ingwall, J.S. Regulation of cardiac AMP-specific 5'-nucleotidase during ischemia mediates ATP resynthesis on reflow. Am. J. Physiol., 1998, 274(Pt 1), C992-C1001.
63. Hancock, C.R.; Brault, J.J.; Terjung, R.L. Protecting the cellular energy state during contractions: role of AMP deaminase. J. Physiol. Pharmacol., 2006, 57(Suppl 10), 17-29.
64. Kulkarni, S.S.; Karlsson, H.K.; Szekeres, F.; Chibalin, A.V.; Krook, A.; Zierath, J.R. Suppression of 5'-nucleotidase enzymes promotes AMP-activated protein kinase (AMPK) phosphorylation and metabolism in human and mouse skeletal muscle. J. Biol. Chem., 2011; 286(40), 34567-34574.
65. Plaideau, C.; Liu, J.; Hartleib-Geschwindner, J.; Bastin-Coyette, L.; Bontemps, F.; Oscarsson, J.; Hue, L.; Rider, M.H. Overexpression of AMP-metabolizing enzymes controls adenine nucleotide levels and AMPK activation in HEK293T cells. FASEB J., 2012, 26(6), 2685-2694.
66. Corton, J.M.; Gillespie, J.G.; Hardie, D.G.. . Role of the AMPactivated protein kinase in the cellular stress response. Curr. Biol., 1994, 4(4), 315-324.
67. Salt, I.P; Johnson, G.; Ashcroft, S.J.; Hardie, D.G.. AMP-activated protein kinase is activated by low glucose in cell lines derived from pancreatic beta cells, and may regulate insulin release. Biochem. J., 1998, 335(Pt 3), 533-539.
68. Ipata, P.L.; Balestri, B. Glycogen as a fuel: metabolic interaction between glycogen and ATP catabolism in oxygen-independent muscle contraction. Metabolomics, 2012, 8(1), 1736-1741.
69. Zhou, G.; Myers, R.; Li, Y.; Chen, Y.; Shen, X.; Fenyk-Melody, J.; Wu, M.; Ventre, J.; Doebber, T.; Fujii, N.; Musi, N.; Hirshman, M.F.; Goodyear, L.J.; Moller, D.E. Role of AMP-activated protein kinase in mechanism of metformin action. J. Clin. Invest., 2001, 108(8), 1167-1174.
70. Ouyang, J.; Parakhia, R. A.; Ochs, R.S. Metmorfin activates AMP kinase through inhibition of AMP deaminase. J. Biol. Chem., 2011, 286(1), 1-11.
71. Itoh, R.; Yamada, K. Determination of 5'-nucleotidase which preferentially hydrolyses 6-hydroxypurine nucleotides in pig, rat and human tissues by immunotitration. Int. J. Biochem., 1991, 23(4), 461-465.
72. Itoh, R.; Echizen, H.; Higuchi, M.; Oka, J.; Yamada, K. A comparative study on tissue distribution and metabolic adaptation of IMP-GMP 5'-nucleotidase. Comp. Biochem. Physiol., B: Comp. Biochem., 1992, 103(1), 153-159.
73. Bretonnet, A.S.; Jordheim, L.P.; Dumontet, C.; Lancelin, J.M. Regulation and activity of cytosolic 5-nucleotidase II: A bifunctional allosteric enzyme of the Haloacid Dehalogenase superfamily involved in cellular metabolism. FEBS Lett., 2005, 579(16), 3336-3368.
74. Veiga-da-Cunha, M.; Vleugels, W.; Maliekal, P.; Matthijs, G.; Van Schaftingen, E. Mammalian phosphomannomutase PMM1 is the brain IMP-sensitive glucose-1,6-bisphosphatase. J. Biol. Chem., 2008, 283(49), 33988-33993.
75. Guha, S.K., Rose, Z.B. Brain glucose bisphosphatase requires inosine monophosphate. J. Biol. Chem., 1982, 257(12), 6634-6637.
76. Guha, S.K.; Rose, Z.B. Role of inosine 5'-phosphate in activating glucose-bisphosphatase. Biochemistry, 1983, 22(6), 1356-1361.
77. Filoni, D.N.; Pesi, R.; Careddu, M.G.; Camici, M.; Allegrini, S.; Collavoli, A.; Scarfone, I.; Zucchi, F.; Galli, A.; Tozzi, M.G. Initial studies to define the physiologic role of cN-II. Nucleosides Nucleotides Nucleic Acids, 2011, 30(12), 1155-1160.
78. Wallden, K.; Stenmark, P.; Nyman, T.; Flodin, S.; Graslund, S.; Loppnau, P.; Bianchi, V.; Nordlund, P. Crystal structure of human cytosolic 5'-nucleotidase II: insights into allosteric regulation and substrate recognition. J. Biol. Chem., 2007, 282, 17828-17836.
79. Wallden, K.; Nordlund, P. Structural basis for the allosteric regulation and substrate recognition of human cytosolic 5'-nucleotidase II. J. Mol. Biol., 2011, 408, 684-696.
80. Allegrini, S.; Careddu, M.G.; Filoni, D.N.; Camici, M.; Tozzi, M.G. Active and regulatory sites of cytosolic 5'-nucleotidase. FEBS J., 2010, 277, 4863-4872.
81. Banditelli, S.; Baiocchi, C.; Pesi, R.; Allegrini, S.; Turriani, M.; Ipata, P.L.; Camici, M.; Tozzi, M.G. The phosphotransferase activity of cytosolic 5'-nucleotidase; a purine analog phosphorylating enzyme. Int. J. Biochem. Cell Biol., 1996, 2, 711-720.
82. Allegrini, S.; Scaloni, A.; Ferrara, L.; Pesi, R.; Pinna, P.; Sgarrella, F.; Camici, M.; Eriksson, S.; Tozzi, M.G. Bovine cytosolic 5'-nucleotidase acts through the formation of an aspartate 52-phosphoenzyme intermediate. J. Biol. Chem., 2001, 276, 33526-33532.
83. Goodman, M.N.; Lowenstein, J.M. The purine nucleotide cycle. Studies of ammonia production by skeletal muscle in situ and in perfused preparations. J. Biol. Chem., 1977, 252(14), 5054-5060.
84. Van Waarde, A. Operation of the purine nucleotide cycle in animal tissues. Biol. Rev., 1988, 63(2), 259-298.
85. Ipata P.L. Mechanism of ATP loss in nonoxidative contracting muscle. Adv. Physiol. Educ., 2011, 35, 92-94.
86. Norman, B.; Glenmark, B.; Jansson, E. Muscle AMP deaminase deficiency in 2% of a healthy population. Muscle. Nerve, 1995, 18(2), 239-241.
87. Fischer, H.; Esbjörnsson, M.; Sabina, R.L.; Strömberg, A.; Norman, B. AMP deaminase deficiency is associated with lower sprint cycling performance in healthy subjects. J. Apll. Physiol., 2007, 103(1), 315-322.
88. Sahlin, K.; Palmskog, G.; Hultman, E. Adenine nucleotide and IMP contents of the quadriceps muscle in man after exercise. Pflügers Arch., 1978, 374, 193-198.
89. Fukui, H.; Taniguchi, S.I.; Yoshihiko, U.; Yoshida, A.; Ohtahara, A.; Hisatome, I.; Shigemasa, C. Enhanced activity of the Purine Nucleotide Cycle of the exercising muscle in patients with Hyperthyroidism. J. Clin. Endocrinol. Metab., 2001, 86(5), 2205-2210.
90. Gaitanos, G.; Williams, C.C.; Boobis, L.H.; Brooks, S. Human muscle metabolism during intermittent maximal exercise. J. Appl. Physiol., 1993, 75, 712-719.
91. Tullson, P.C.; Teriung, R. Adenine nucleotide degradation in striated muscle. Int. J. Sports Med., 1990, 11, S47-S55.
92. Dawson, M.J.; Gadian, D.G.; Wilkie, D.R. Muscular fatigue studied by phosphorus nuclear magnetic resonance in the frog. J. Physiol., 1978, 282, 20P-21P.
93. Stathis, C.G.; Zhao, S.; Carey, M.F; Snow, R.J. Purine loss after repeated sprint bouts in humans. J. Appl. Physiol., 1999, 87, 2037-2042.
94. Macedo, D.V.; Lazarim, F.L.; Catanho da Silva, F.O.; Tessuti, L.S.; Hohl, R. Is lactate production related to muscular fatigue? A pedagogical proposition using empirical facts. Adv. Physiol. Educ., 2009, 33, 302-307.
95. Barankiewicz, J.; Gelfand, E. W.; Issekutzg, A.; Cohen, A. Evidence for active purine nucleoside cyclesin human mononuclear cells and cultured fibroblasts. J. Biol. Chem., 1982, 257(19), 11597-1160.
96. Berman, P.A.; Human, L. Regulation of 5'-phosphoribosyl-1-pyrophosphate and of hypoxanthine uptake and release in human erythrocytes by oxypurine cycling. J. Biol. Chem., 1990, 265(12), 6562-6568.
97. Barsotti, C.; Pesi, R.; Felice, F.; Ipata, P.L. The purine nucleoside cycle in cell-free extracts of rat brain: evidence for the occurrence of an inosine and a guanosine cycle with distinct metabolic roles. Cell. Mol. Life Sci., 2003, 60(4), 786-793.
98. Hatanaka, M.; Del Giudice, R.; Long, C. Adenine formation from adenosine by mycoplasmas: adenosine phosphorylase activity. Proc. Natl. Acad. Sci., 1975, 72(4), 1401-1405.
99. Barsotti, C.; Tozzi, M.G.; Ipata, P.L. Purine and pyrimidine salvage in whole rat brain. Utilization of ATP-derived ribose-1-phosphate and 5-phosphoribosyl-1-pyrophosphate generated in experiments with dialyzed cell-free extracts. J. Biol. Chem., 2002, 277(12), 9865-9869.
100. Amici, A.; Emanuelli, M.; Ferretti, E.; Raffaelli, N.; Ruggeri, S.; Magni, G. Homogeneous pyrimidine nucleotidase from human erythrocytes: enzymatic and molecular properties. Biochem. J., 1994, 304(3), 987-992.
101. Grobosky, C.L.; Lopez, J.B.; Rennie, S.B.; Skopelitis, D.J.; Wiest, A.T.; Bingman, C.A.; Bitto, E. Structural Basis of Substrate Specificity and Selectivity of Murine Cytosolic 5-Nucleotidase III. J. Mol. Biol., 2012, 423(4), 540-554.
102. Rees, C.R.; Duley, J.D.; Marinaki, A.M. Pyrimidine 5-nucleotidase deficiency. Br. J. Haematol., 2003, 120(3), 375-383.
103. Zanella, A.; Bianchi, P.; Fermo, E. Hereditary pyrimidine 5'-nucleotidase deficiency: from genetics to clinical manifestations. Br. J. Haematol., 2006, 133(2), 113-123.
104. Rampazzo, C.; Johansson, M.; Gallinaro, L.; Ferraro, P.; Hellman, U.; Karlsson, A.; Reichard, P.; Bianchi, V. Mammalian 5'(3')-deoxyribonucleotidase: cDNA cloning and overexpression of the enzyme in Escherichia coli and mammalian cells. J. Biol. Chem., 2000, 275(8), 5409-5415.
105. Mazzon, C.; Rampazzo, C.; Scaini, M.; Gallinaro, L.; Karlsson, A.; Meier, C.; Balzarini, J.; Reichard, P.; Bianchi V. Cytosolic and mitochondrial deoxyribonucleotidases: activity with substrate analogs, inhibitors and implications for therapy. Biochem. Pharmacol., 2003, 66(3), 471-479.
106. Beutler, E.; Hartman, G. Age-related red cell enzymes in children with transient erythroblastopenia of childhood and with hemolytic anemia. Pediatr. Res., 1985, 19(1), 44-47.
107. Hokari, S.; Miyazaki, T.; Hasegawa, M.; Komoda, T. Enhanced activity of pyrimidine 5'-nucleotidase in rat red blood cells during erythropoiesis. Biol. Chem., 1998, 379(3), 329-333.
108. Valentine, W.N.; Anderson, H.M.; Paglia, D.E.; Jaffé, E.R.; Konrad, P.N.; Harris, S.R. Studies on human erythrocyte nucleotide metabolism. II. Nonspherocytic hemolytic anemia, high red cell ATP, and ribosephosphate pyrophosphokinase (RPK, E.C.2.7.6.1) deficiency. Blood, 1972, 39(5), 674-684.
109. Valentine, W.N.; Fink, K.; Paglia, D. E.; Harris, S.R.; Adams, W.S. Hereditary hemolytic anemia with human erythrocyte pyrimidine 5'-nucleotidase deficiency. J. Clin. Invest., 1974, 54(4), 866-879.
110. Paglia, D.E.; Valentine, W.N. Hereditary and acquired defects in the pyrimidine nucleotidase of human erythrocytes. Curr. Top. Hematol., 1980, 3, 75-109.
111. Amici, A.; Emanuelli, M.; Raffaelli, N.; Ruggieri, S.; Saccucci, F.; Magni, G. Human erythrocyte pyrimidine 5'-nucleotidase, PN-I, is identical to p36, a protein associated to lupus inclusion formation in response to alpha-interferon. Blood, 2000, 196(4), 1596-1598.
112. Rich, S.; Bose, M.; Tempst, P.; Rudolfsky, U. Purification, microsequencing, and immunolocalization of p36, a new interferon-induced protein that is associated with human lupus inclusions. J. Biol. Chem., 1996, 271(2), 1118-1126.
113. Buschmann, J.; Moritz, B.; Jeske, M.; Lilie, H.; Schierhorn, A.;Wahle, E. Identification of Drosophila and Human 7-Methyl GMP-specific Nucleotidases. J. Biol. Chem., 2013, 288(4), 2441-2451.
114. Parkinson, F.E.; Damaraju, V.L.; Graham, K.; Yao, S.Y.; Baldwin, S.A.; Cass, C.E.; Young, J.D. Molecular biology of nucleoside transporters and their distributions and functions in the brain. Curr. Top. Med. Chem. 2011, 11(8), 948-972.
115. Balestri, F.; Barsotti, C.; Lutzemberger, L.; Camici, M.; Ipata, P.L. Key role of uridine kinase and uridine phosphorylase in the homeostatic regulation of purine and pyrimidine salvage in brain. Neurochem. Int., 2007, 51(8), 517-523.
116. Bontemps, F.; Van den Berghe, G.; Hers, H.G. Evidence for a substrate cycle between AMP and adenosine in isolated hepatocytes. Proc. Natl. Acad. Sci., 1983, 80(10), 2829-2833.
117. Hunsucker, S.A.; Mitchell, B.S.; Spychala, J.http://www.science direct.com/science/article/pii/S0163725805000227-aff1 The 5-nucleotidases as regulators of nucleotide and drug metabolism. Pharmacol. Ther., 2005, 107(1), 1-30.
118. Okuda, H.; Higashi, Y.; Nishida, K.; Fujimoto, S.; Nagasawa, K. Contribution of P2X7 receptors to adenosine uptake by cultured mouse astrocytes. Glia, 2010, 58(14), 1757-1765.
119. Abbracchio, M.P.; Burnstock, G.; Verkhratsky, A.; Zimmermann, H. Purinergic signalling in the nervous system: an overview. Trends Neurosci., 2009, 32(1), 19-29.
120. Ipata, P.L.; Balestri, F.; Camici, M.; Tozzi, M.G. Molecular mechanisms of nucleoside recycling in the brain. Int. J. Biochem. Cell Biol., 2011, 43(1), 140-145.
121. James, S.; Richardson, P.J. Production of adenosine from extracellular ATP at the striatal cholinergic synapse. J. Neurochem., 1993, 60(1), 219-227.
122. Ipata, P.L.; Barsotti, C.; Tozzi, M.G.; Camici, M.; Balestri, F. Metabolic interplay between intra-and extra-cellular uridine metabolism via an ATP driven uridine-UTP cycle in brain. Int. J. Biochem. Cell. Biol., 2010, 42(6), 932-937.
123. Kovács, Z.; Juhász, G.; Palkovits, M.; Dobolyi, A.; Kékesi, K. A. Area, age and gender dependence of the nucleoside system in the brain: a review of current literature Curr. Top. Med. Chem., 2011, 11(8), 1012-1033.
124. Pesi, R.; Micheli, V.; Jacomelli, G.; Peruzzi L.; Camici, M.; Garcia-Gil, M.; Allegrini, S.; Tozzi, M. G.. Cytosolic 5'-nucleotidase hyperactivity in erythrocytes of Lesch-Nyhan syndrome patients. Neuroreport, 2000, 11(9), 1827-1831.
125. Tzoneval, G.; Perez-Garcial, A.; Carpenter, Z.; Khiabanian, H.; Tosello, V.; Allegretta, M.; Paietta, E.; Racevskis, J.; Rowe, J. M.; Tallman, M. S.; Paganin, M.; Basso, G.; Hof, J.; Kirschner-Schwabe,R.; Palomero, T.; Rabadan, R.; Adolfo Ferrando, A. Activating mutations in the NT5C2 nucleotidase gene drive chemotherapy resistance in relapsed ALL. Nat. Med., 2013, 19, 368-371.
126. Kovacs, Z.; Dobolyi, A. Anatomical distribution of nucleoside system in the human brain and implications for therapy. In Adenosine, Susan Masino & Detlev Boison, Ed.; Springer Science+ Business Media New York, 2013, pp.612-656.